Clinical Trial

The ArtixASCEND Study

Recruiting
View on ClinicalTrials.gov →
Summary
This study is a post-market, prospective, multicenter, single-arm study to evaluate the safety and effectiveness of the Artix Thrombectomy System in patients with acute lower extremity arterial occlusions.
Protocol Amendment History 4 changes
notable Trial sites expanded: 17 -> 20 locations 2026-08-08
notable Trial sites expanded: 14 -> 17 locations 2026-07-15
notable Trial sites expanded: 11 -> 14 locations 2026-06-03
notable Trial sites expanded: 5 -> 11 locations 2026-05-12
Trial Details
NCT Number NCT07135895
Lead Sponsor Inari Medical
Conditions Acute Lower Limb Arterial Occlusion
Enrollment 250 participants
Start Date 2026-01-07
Primary Completion 2029-03-01 (estimated)
Study Completion 2029-10-01 (estimated)
Updated on ClinicalTrials.gov 2026-08-07